Peter Lobie

Lobie Peter

  • Professor, Department of Pharmacology
  • Senior Principal Investigator, Cancer Science InstituteĀ of Singapore, National University of Singapore
Administrative Appointment(s)
  • Chair of Graduate Committee, Cancer Science Institute of Singapore, National University of Singapore
Joint Appointment(s)
  • Honorary Professor, University of Science and Technology of China, China
Academic Qualifications
  • PhD, Karolinska Institutet, Stockholm, Sweden
  • B.Med.Sci, University of Queensland, Australia
  • MBBS (Honours, First Class), University of Queensland, Australia
Research Interest(s)
  • Breast Cancer
  • TFF
  • Therapeutics
Recent Publications
  • 1. Gilandoust, M., Harsha, K. B., Mohan, C. D., Raquib, A. R., Rangappa, S., Pandey, V., . . . Rangappa, K. S. (2018). Synthesis, characterization and cytotoxicity studies of 1,2,3-triazoles and 1,2,4-triazolo [1,5-a] pyrimidines in human breast cancer cells. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 28(13), 2314-2319. doi:10.1016/j.bmcl.2018.05.020.
  • 2. Tan, S., Li, H., Zhang, W., Shao, Y., Liu, Y., Guan, H., . . . Zhu, T. (2018). NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression. Oncogene, 1-14. doi:10.1038/s41388-018-0280-6.
  • 3. Bui, N. -L. -C., Pandey, V., Zhu, T., Ma, L., Basappa., & Lobie, P. E. (2018). Bad phosphorylation as a target of inhibition in oncology. CANCER LETTERS, 415, 177-186. doi:10.1016/j.canlet.2017.11.017.
  • 4. Ding, K., Tan, S., Huang, X., Wang, X., Li, X., Fan, R., . . . Wu, Z. (2018). GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis. JOURNAL OF BIOLOGICAL CHEMISTRY, 293(11), 3949-3964. doi:10.1074/jbc.RA117.001103.
  • 5. Fielder, G. C., Yang, T. W. -S., Razdan, M., Li, Y., Lu, J., Perry, J. K., . . . Liu, D. -X. (2018). The GDNF Family: A Role in Cancer?. NEOPLASIA, 20(1), 99-117. doi:10.1016/j.neo.2017.10.010.